Novel triacsin C analogs were synthesized and found to be highly effective against rotavirus replication at low micromolar or nanomolar concentration ranges with high therapeutic indices in cell culture. 
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Introduction
Rotaviruses are non-enveloped, icosahedral viruses with an 11-segment doublestranded RNA genome [1] . The capsid of rotavirus is composed of the outer capsid proteins, VP4 and VP7, and the major inner capsid protein, VP6. Rotaviruses are divided into 7 (A to G) antigenically distinct serogroups based on VP6. Among them, group A rotaviruses are the leading cause of severe gastroenteritis in infant and children worldwide, associated with over 500,000 death in children younger than 5 years of age each year, although attenuated live vaccines are available [1] [2] [3] . Majority of rotavirus infection-associated mortality occurs in the developing countries. Nonetheless, nearly 1 in 80 children is hospitalized with rotavirus gastroenteritis by 5 years of age in the US [1] [2] [3] . Since there are no specific antiviral agent for rotavirus infection, the treatment options for rotavirus infection are limited to providing oral rehydration solution to restore and maintain hydration until the infection resolves [4] . However, the development of rotavirus antivirals to reduce the severity of diseases and duration of rotavirus-related hospitalization has been impeded by limited information on the therapeutic targets for rotaviruses.
Previously it was shown that disruption of lipid rafts and/or lipid droplets decrease infectious rotaviruses by inhibition of rotavirus morphogenesis [5, 6] . Lipid droplets are cellular organelles for storage of neutral fats such as TG and cholesterol ester, and play a crucial role in regulating cellular lipid levels. Lipid rafts are microdomains in cell membrane enriched in cholesterol, glycosphingolipids, and proteins. These structures M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
4 are found important for infectious virus particle formation of human hepatitis C virus (HCV) [7, 8] and dengue virus [9] , suggesting the importance of lipid homeostasis in virus replication. Recently our group has demonstrated that rotavirus replication induced an increase in the TG levels in cells, and suppression of increase in TG levels by farnesoid X receptor (FXR) agonists significantly inhibited rotavirus replication [10] .
Lipogenesis is the process of producing fats from acetyl-CoA, which is then stored as an energy source. During lipogenesis, fatty acid (FA) is synthesized (de novo synthesis) from acetyl-CoA, and subsequently esterified with glycerol to form TG.
Numerous enzymes participate in lipogenesis, which include fatty acid synthase (FASN), long chain fatty acid acyl-CoA synthetase (ACSL) 1-6, and diacylglycerol acyltransferase (DGAT) 1/2 and Acyl-CoA:cholesterol acyltransferase (ACAT)1/2 [11] [12] [13] [14] [15] . Lipolysis is the reverse pathway of lipogenesis to generate acetyl-CoA and energy from TG in which process multiple enzymes including lipases are involved. In this study, we found that the commercially available inhibitors for FASN, ACSL, DGAT and ACAT significantly reduced the replication of rotaviruses in vitro. Since triacsin C, a fungal metabolite from Streptomyces aureofaciens, is an ACSL inhibitor and showed the most potent inhibition on rotavirus replication, we synthesized its analogs and examined their antiviral effects against rotavirus. The synthetic sequence is straightforward and efficient (Scheme 1 and 2), which would provide flexibility for further optimization. Among the triacsin C and its analogs, 1e is the most potent against rotavirus replication with the effective dose that reduce 50% of the virus replication (ED 50 ) of 0.1 µM. Our results suggest that lipogenic enzymes may represent potential therapeutic targets for rotavirus M A N U S C R I P T
5 infection, and triacsin C analogs may be useful as therapeutic options for rotavirus infection.
Biochemical studies.
The effects of commercially available inhibitors for lipogenesis as well as newly synthesized triacsin C analogs (described below) were examined in rotavirus replication 
Chemistry
Various triascin C analogs were synthesized from (E,E,E)-2,4,7-undecatrienal (1), which was prepared by a modification of the reported procedure [16, 17] (Scheme 1). Hence, bromination of (E)-2-hexen-1-ol (2) with phosphorus tribromide in dichloromethane followed by a displacement reaction with 3-(tetrahydropyranyloxy)propynyl magnesium bromide and a catalytic amount of copper cyanide afforded enyne 3. Removal of the THP protecting group of 3 with oxalic acid in refluxing methanol followed by selective reduction of the propagylic alcohol function with lithium aluminum hydride in diethyl should be noted that the synthesis of triacsin C from aldehyde 1 has been reported by Tanaka et al. [17] in less than 0.5% yield from a three-step sequence of reactions. 1e not only has a greater bioactivity than triacsin C, its chemical yield is 44% prepared from aldehyde 1 in one step.
Results and discussion
All inhibitors, cerulenin, C75, triacsin C, troglitazone, A922500, betulinic acid, CI-976 These results indicate that disruption of lipogenesis induced by rotavirus replication at any step significantly inhibited the virus replication.
Triacsin C is an analog of polyunsaturated FA, having an 11-carbon alkenyl chain with a N-hydroxytriazene moiety at the terminus, and competitively inhibits ACSL 1, 3, and 4 [21] . ACSL is a family of enzymes that converts long chain FA to acyl-CoA, which serves as a substrate at each cascading step in the synthesis of various lipid molecules including TG and cholesteryl ester. In mammals, five isoforms of ACSLs are identified (ACSL 1, 3-6) [12] . In lipid droplet-enriched fractions from Huh7 cells, ACSL 3 is the most abundant isoform and ACSL 4 is a minor constituent [19] . The role of ACSL3 seems to be important in the synthesis of neutral lipids in lipid droplets, suggested by the finding that the addition of oleic acid as a source of FA in the cells led to the accumulation of lipid droplets in association with increased levels of ACSL 3 in lipid droplets [20] .
By inhibiting ACSL, triacsin C consequently blocks the synthesis of TG, diglycerides, and cholesterol esters [22] . Troglitazone, a member of the thiazolidinediones family, is an anti-diabetic and anti-inflammatory drug. It is also known to inhibit ACSL4 (but not other ACSL isoforms), and decreased the size of lipid droplets in cells [23] . In our study, both triacsin C and troglitazone significantly reduced the replication of rotavirus. Furthermore, addition of triacsin C directly to the medium of cell culture showed potent antivirus effects against rotavirus replication, suggesting that triacsin C readily penetrates the cells.
Since triacsin C strongly inhibited rotavirus replication, we synthesized various analogs of triacsin C, and examined their effects in rotavirus replication and toxicity in MA104 cells. The effective synthetic analogs against rotaviruses are shown in Table 1 M A N U S C R I P T In this study, we demonstrated that rotavirus replication is closely associated with lipid metabolism, and inhibition of lipogenic enzymes significantly decreased rotavirus replication. We have also synthesized novel triacsin C analogs by modification of the alkylidene-terminal end for evaluation of anti-rotavirus activity, and found one of the novel analogs, 1e, was highly effective against rotavirus replication. The facile and high-M A N U S C R I P T
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10 yielding synthesis of the analogs would provide flexibility for further optimization. Based on these findings, the lipogenic enzymes may serve as potential therapeutic targets for rotavirus infection and triacsin C analogs as potential therapeutic options for rotavirus infections.
Experimental.
General
NMR spectra were obtained from a 400-MHz spectrometer (Varian Inc.), in procedure [16, 17] was used to prepare (E,E,E)-2,4,7-undecatrienal (1), and spectral data of all synthetic intermediates including 13 C NMR data (which were not reported in previous publications [16, 17] ) are included herein. 
.
To a solution of 0.43 g (2.6 mmol) of (E,E,E)-2,4,7-undecan-1-ol in 3 mL of DMSO under argo was added 0.91 g (3.3 mmol) of IBX, and the solution was stirred at 
(E)-N'-[(2E,4E,7E)-Undeca-2,4,7-trienylidene]propane-2-sulfonohydrazide (1c).
Following a similar reaction sequence as that described for 1a, from 25 mg (0.15 mmol)
of aldehyde 1 and 42 mg (0.31 mmol) of propane-2-sulfonohydrazide, gave 32 mg (74% yield) of 1c. 
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Highlights > Rotaviral diarrheal remained as one of the most important causes for mortality worldwide. > there is no specific antiviral drug for rotavirus infection. > Triacsin C, a fungal metabolite, was found to be highly effective against rotavirus replication. > One triacsin C analog, TC20, was highly effective in a nanomolar concentration range with a high therapeutic index. > Triacsin C and/or its analogs are potential therapeutic options for rotavirus infections.
